Biodel to Present at 2013 BIO CEO and Investor Conference

Biodel to Present at 2013 BIO CEO and Investor Conference

DANBURY, Conn., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD)
announced today that management will be presenting an overview of the
company's technologies, development programs, and outlook at the 2013 BIO CEO
and Investor Conference on Monday, February 11, 2013 at 3:00 p.m. ET during
the conference to be held February 11-12, 2013, at the Waldorf Astoria Hotel
in New York City.

A live and archived webcast of the presentation will be accessible by visiting
the Biodel website at www.biodel.comunder "Webcasts" in the "News & Events"
section.

About Biodel Inc.

Biodel Inc.is a specialty biopharmaceutical company focused on the
development and commercialization of innovative treatments for diabetes that
may be safer, more effective and more convenient for patients. We develop our
product candidates by applying our proprietary formulation technologies to
existing drugs in order to improve their therapeutic profiles.

BIOD-G

CONTACT: Seth D. Lewis, +1-646-378-2952